Galapagos announces expanded drug discovery collaboration with Schering-Plough
Building on a collaboration established in May 2009 and expanded this month, BioFocus DPI scientists will work with two of SPRI's European sites on these drug discovery projects.
"We are pleased to build on our collaborative relationship with SPRI, which has evolved into one of the larger for BioFocus DPI this year with over 20 research staff currently engaged," said Onno van de Stolpe, CEO of Galapagos. "BioFocus DPI has proven resilient in securing large collaborations with strong partners, amidst consolidation and reorganization in the pharma industry."
Most read news
Organizations
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.